← feed

Is NCT03126721 results overdue?

Yes — results are overdue. Primary completion was 2017-07-11; the FDAAA-801 reporting deadline (2018-07-11) passed 2902 days ago and no results are posted on ClinicalTrials.gov.

The Study is to Evaluate the Effect of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults

NCT IDNCT03126721 ↗
SponsorPfizer (INDUSTRY)
Public issuerPFIZER INC — PFE (CIK 0000078003) best-effort name match, 95% conf — verify on EDGAR ↗
PhasePHASE1
StatusCOMPLETED
Primary completion2017-07-11 (ACTUAL)
Reporting deadline2018-07-11 (completion + 365d)
Days overdue2902
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 8a61d8ae7003ec8b… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03126721. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →